X4 Pharmaceuticals

XFOR

Börsenwert 332 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	11,3 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	10 Mio. $	–	–	–
3	3 BlackRock New York	7,5 Mio. $	+371.937 $	+17.824	+5 %
4	4 Vanguard Group Malvern, Pennsylvania	5,65 Mio. $	+104.816 $	+5.023	+2 %
5	5 OrbiMed New York	4,77 Mio. $	–	–	–
6	KCM 6 Kingdon Capital Management New York	3,1 Mio. $	+10.434 $	+500	+0,3 %
7	7 Adage Capital Partners Boston, Massachusetts	2,86 Mio. $	–	–	–
8	8 Perceptive Advisors New York	2,37 Mio. $	–	–	–
9	9 Geode Capital Management Boston, Massachusetts	2,31 Mio. $	-47.327 $	-2.268	-2 %
10	10 Axa Paris, France	2,06 Mio. $	+605 $	+29	+0 %
11	11 State Street Boston, Massachusetts	1,98 Mio. $	+131.547 $	+6.304	+7 %
12	12 Ensign Peak Advisors Salt Lake City, Utah	1,7 Mio. $	–	–	–
13	13 Schonfeld Strategic Advisors New York	1,29 Mio. $	+452.902 $	+21.704	+51 %
14	14 Pale Fire Capital SE Prague, Czech Republic	1,07 Mio. $	+991.714 $	+47.525	+805 %
15	15 UBS O'Connor Chicago, Illinois	1,04 Mio. $	+270.460 $	+12.961	+34 %
16	16 Northern Trust Chicago, Illinois	883.208 $	+183.360 $	+8.787	+25 %
17	17 Sio Capital Management New York	872.438 $	-832.121 $	-39.877	-48 %
18	18 Parkman Healthcare Partners Stamford, Connecticut	547.974 $	+8.430 $	+404	+2 %
19	19 AQR Capital Management Greenwich, Connecticut	479.033 $	+202.871 $	+9.722	+69 %
20	20 Point72 Asset Management Stamford, Connecticut	418.347 $	+57.009 $	+2.732	+15 %
21	21 GSA Capital Partners London, United Kingdom	340.000 $	+353.136 $	+16.923	Neu
22	22 Nuveen Charlotte, North Carolina	333.810 $	–	–	–
23	23 Morgan Stanley New York	328.401 $	+181.753 $	+8.710	+114 %
24	24 Charles Schwab San Francisco, California	293.293 $	–	–	–
25	25 Millennium Management New York	243.095 $	+13.772 $	+660	+6 %

X4 Pharmaceuticals XFOR Börsenwert 332 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 332 Mio. $